Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro

YC Yeh, LH Doan, ZY Huang, LW Chu… - Frontiers in …, 2022 - frontiersin.org
COVID-19 is threatening human health worldwide but no effective treatment currently exists
for this disease. Current therapeutic strategies focus on the inhibition of viral replication or …

Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice

H Pan, J He, Z Yang, X Yao, H Zhang, R Li, Y Xiao… - Phytomedicine, 2023 - Elsevier
Abstracts Background Myricetin (3, 5, 7-trihydroxy-2-(3, 4, 5-tri hydroxyphenyl)-4-
benzopyrone) is a common flavonol extracted from many natural plants and Chinese herb …

Kaempferol has potential anti‐coronavirus disease 2019 (COVID‐19) targets based on bioinformatics analyses and pharmacological effects on endotoxin‐induced …

Y Sun, Q Tao, Y Cao, T Yang, L Zhang… - Phytotherapy …, 2023 - Wiley Online Library
COVID‐19 has infected 272 million patients and caused 5.33 million deaths around the
world, and it remains the main global threat. Previous studies revealed that Chinese …

Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice

T Xiao, M Cui, C Zheng, P Zhang, S Ren, J Bao, D Gao… - Inflammation, 2022 - Springer
The emergence of severe acute syndrome coronavirus 2 (SARS-CoV-2) in December 2019
has led to the global COVID-19 pandemic. Although the symptoms of most COVID-19 …

[PDF][PDF] Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?

MFN Meeran, A Seenipandi, H Javed, C Sharma… - Heliyon, 2021 - cell.com
Abstract Coronavirus disease (COVID-19) caused by novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is an ongoing pandemic and presents a public …

[HTML][HTML] Potential treatment of COVID-19 with traditional Chinese medicine: what herbs can help win the battle with SARS-CoV-2?

L Li, Y Wu, J Wang, H Yan, J Lu, Y Wang, B Zhang… - Engineering, 2022 - Elsevier
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the
treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute …

[HTML][HTML] In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

D Zhang, K Wu, X Zhang, S Deng, B Peng - Journal of integrative medicine, 2020 - Elsevier
Objective In this study we execute a rational screen to identify Chinese medical herbs that
are commonly used in treating viral respiratory infections and also contain compounds that …

Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2

L Cheng, W Zheng, M Li, J Huang, S Bao, Q Xu, Z Ma - 2020 - preprints.org
The most recent outbreak of 2019 novel coronavirus, named as COVID-19, caused
pneumonia epidemic in Wuhan with 2,121 deaths cases as of February 20 th 2020 …

[HTML][HTML] In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors

R Singh, VK Bhardwaj, J Sharma, R Purohit… - Journal of traditional and …, 2022 - Elsevier
Background and aim A novel coronavirus, called the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some …

Exploring active compounds of Da-Yuan-Yin in treatment of COVID-19 based on network pharmacology and molecular docking method

Y ZONG - Chinese Traditional and Herbal Drugs, 2020 - pesquisa.bvsalud.org
Objective: To explore the active compound of Da-Yuan-Yin for treatment of coronavirus
disease 2019 (COVID-19). Methods: Based on traditional Chinese medicine system …